Professional
Added to YB: 2025-07-03
Pitch date: 2025-06-30
EPIX [neutral]
ESSA Pharma Inc.
-4.97%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.
Market Cap
$75.5M
Pitch Price
$0.21
Price Target
2.10 (+944%)
Dividend
N/A
EV/EBITDA
1.15
P/E
-2.65
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Clark Street Value Mid Year 2025 Portfolio Review: Current Position - ESSA Pharma Inc.
EPIX (holding update): Trading at $1.75 vs $2.10 est. liquidation value. Major shareholders BML (9.5%), Soleus (5.1%), Kevin Tang (9.7%), and BVF (20%) pushing for liquidation. Management indicated decision coming 'in near future' 53 days ago in Q1 results.
Read full article (1 min)